Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05143229
Title Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer (ASSET)
Acronym ASSET
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Kansas Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The University of Kansas Clinical Research Center RECRUITING Fairway Kansas 66205 United States Details
The University of Kansas Cancer Center - Overland Park RECRUITING Overland Park Kansas 66210 United States Details
The University of Kansas Cancer Center - Indian Creek RECRUITING Overland Park Kansas 66211 United States Details
The University of Kansas Cancer Center RECRUITING Westwood Kansas 66205 United States Details
The University of Kansas Cancer Center - North Kansas City Hospital RECRUITING Kansas City Missouri 64116 United States Details
The University of Kansas Cancer Center - North RECRUITING Kansas City Missouri 64154 United States Details
The University of Kansas Cancer Center - Lee's Summit RECRUITING Lee's Summit Missouri 64064 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field